Anaprazole is a pharmaceutical drug used for the treatment of duodenal ulcers. It is classified as a proton pump inhibitor (PPI). It was approved for use in China in 2023. It is formulated as its sodium salt, anaprazole sodium, in enteric-coated tablets.

References